Quotes by Robert Hazlett

“in the most optimistic scenario.”

“We had heard some investors were expecting a much worse forecast for next year, and those fears have been allayed.”

“Pfizer is clearly a winner here. Pfizer is clearly putting their solid foot forward. Theyve got a good franchise and its good potential for the next couple years.”

“Its not very confidence inspiring to pull your guidance, and because of that were looking hard at our 2006 estimates.”

“We knew 2003 was going to be a challenge, but it appears its going to be more of a challenge than we expected.”

“Even though there may be some good drugs available, it may take some time until they are more widely accepted,”

“For investors in Pfizer, this is a meaningful event. This risk has been a significant overhang for some time.”

“We believe that some [PAH] patients are already using the active ingredient for pulmonary arterial hypertension,”

“The big drug companies are under duress on almost every front. There are challenges everywhere from generics, from the FDA, from managed care and from self-appointed public watchdogs criticizing the industry, and with attacks on direct-to-consumer advertising,”

“Itll be a challenge for [Takeda] by themselves, ... Lilly has historically had a very good presence in the diabetes area. But [Takeda] has got a good drug.”